Patents

PlasmidFactory files at the EPO for plasmid production at 39 °C

Application EP 4 840 965 A1 claims a method that cultures Escherichia coli at a temperature of at least 39 °C to propagate plasmids and minicircles carrying inverted repeats

By Mattia Sapere
3 min read

ShareLinkedInFacebookX

PlasmidFactory files at the EPO for plasmid production at 39 °C
AI-generated cover image

The European Patent Office published application EP 4 840 965 A1 on 18 November 2026. The applicant is PlasmidFactory GmbH, and the filing covers a way of growing Escherichia coli at a temperature of at least 39 °C to propagate plasmids and minicircles that contain at least one inverted repeat. The publication makes the company's patent strategy visible: the claims reach from the production method to the DNA molecules obtained with it.

A1 publication, one applicant, one temperature threshold

The record on the EPO register shows a single applicant, PlasmidFactory GmbH, and a title that names both halves of the filing: “Minicircles with full-length inverted repeats and methods for producing the same”. The document is an A1 publication, meaning a European patent application published with its search report, not a granted patent. Its publication date is 18 November 2026 and the technical field is classified under CPC C12N, the class the EPO uses for micro-organisms and enzymes, including genetic engineering. The single number a reader needs to follow the file is EP 4 840 965 A1; the full text is available in the European Patent Register.

The method: Escherichia coli grown at 39 °C or above

The claimed method is a propagation step. Bacteria of the species Escherichia coli are cultured at a temperature of at least 39 °C, and the cultures carry plasmids and minicircles that include at least one inverted repeat, a sequence that reads the same forwards and backwards on the two strands of the DNA double helix. A minicircle, in this context, is a small circular DNA molecule used to carry genetic material. The application describes the method as a way of propagating those constructs in the bacteria, rather than as a new molecule in itself.

Three families of claims, from the process to the product

The claims summarised in the abstract fall into three groups. First, the method for propagating plasmids and minicircles that contain at least one inverted repeat in E. coli, defined by the culture temperature. Second, a plasmid or minicircle comprising a cargo nucleic acid with at least one inverted repeat that can be obtained by that method. Third, a cargo nucleic acid with at least one inverted repeat obtainable the same way. Claiming the product “obtainable by” the process is a common way to protect DNA molecules that are defined by how they were made, not only by their sequence. That is the intellectual property core of the file: the temperature step is the lever, and the DNA constructs are the subject matter.

What the record does not say, and what happens next

The abstract gives no figures: no yield, no comparison with cultures grown at the standard 37 °C, no data on how the inverted repeats behave at the higher temperature. No inventor is named in the record described here, and no national or PCT phase is mentioned. The next step is ordinary examination, in which EPO examiners compare the claims with the prior art on plasmid propagation and decide whether the temperature threshold is new and inventive. Until a grant is recorded, the filing gives PlasmidFactory a published position in biotechnology, not an enforceable right.

Read also on The Patent: Federal Circuit rejects Netlist defense on two memory module patents · Songs from the same genre or era trigger similar memories

AI-assisted article